Lineage Cell Therapeutics, Inc.
LCTXHealthcare|Biotechnology|US
$1.02
+0.04 (+3.75%)
Tangible Book / Share
$0.07
Cash / Share
$0.20
Clinical Trials (5)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT06841770 A Study to Evaluate the Safety of a Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord Injury | Spinal Cord Injury Cervical, Spinal Cord Injury Thoracic | P1 | Recruiting | 10 | Open-label | OPC1 |
| NCT05919563 LTFU Study of Subjects Who Received GRNOPC1 | Spinal Cord Injuries | Active | 5 | — | — | |
| NCT05975424 LTFU Study of Subjects With Cervical SCI Who Received AST-OPC1 | Spinal Cord Injuries | Active | 25 | — | — | |
| NCT02302157 Dose Escalation Study of AST-OPC1 in Spinal Cord Injury | Cervical Spinal Cord Injury, Spine Injury | P1P2 | Completed | 25 | Open-label | AST-OPC1 |
| NCT01217008 Safety Study of GRNOPC1 in Spinal Cord Injury | Spinal Cord Injury | P1 | Completed | 5 | Open-label | GRNOPC1 |